[ARAY] Accuray Incorporated

Overview

Type of security: Stock

Sector: Health Care

Industry: Medical/Dental Instruments

Market Capitalization: 432.92 M

Exchange: NASDAQ

The data is delayed by 15 minutes.

 

Price: 4.6 Change: -0.15 (-3.16%)
Ext. hours: Change: 0 (0%)

chart ARAY

Refresh chart

Strongest Trends Summary For ARAY

ARAY is in the medium-term down -15% in 3 weeks and down -30% below S&P in 4 months and down -51% below S&P in 1 year. In the long-term down -83% below S&P in 8 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart

 

Description: Accuray Incorporated designs, develops, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the body. The company offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of various types of cancer and tumors in the body. Its CyberKnife System automatically tracks, detects, and corrects for tumor and patient movement in real-time during the procedure, as well as enables delivery of precise, high dose radiation while patients breathe normally. The company also offers the TomoTherapy System, which consists of an integrated and versatile radiation therapy system used for the treatment of a range of cancer types. Accuray Incorporated markets its products in the United States directly, as well as through a sales agent and group purchasing organizations; and directly and through distributors in Europe, Japan and rest of Asia, South America, and internationally to hospitals and stand-alone treatment facilit

Fundamental Ratios
Shares Outstanding80.92 M EPS-0.38 EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters -4.4% Sales Growth - Q/Q-0.65% P/E-11.45
P/E To EPS Growth P/S1.14 P/BV5.66 Price/Cash Per Share2.84
Price/Free Cash Flow-37.37 ROA-9.58% ROE-58.08% ROI-15.43%
Current Ratio2.1 Quick Ratio1.44 Long Term Debt/Equity1.1 Debt Ratio2.17
Gross Margin37.73% Operating Margin-5.88% Net Profit Margin-11.69% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities4.71 M Cash From Investing Activities18.63 M Cash From Operating Activities-12.6 M Gross Profit38.66 M
Net Profit-2.97 M Operating Profit1.17 M Total Assets463.66 M Total Current Assets347.97 M
Total Current Liabilities165.79 M Total Debt200.99 M Total Liabilities387.18 M Total Revenue97.52 M
Technical Data
High 52 week5.28 Low 52 week3.31 Last close3.56 Last change-4.04%
RSI35.48 Average true range0.17 Beta1.14 Volume646.59 K
Simple moving average 20 days-7.48% Simple moving average 50 days-5.85% Simple moving average 200 days-14.65%
Performance Data
Performance Week-8.25% Performance Month-2.47% Performance Quart-14.01% Performance Half-30.47%
Performance Year-6.32% Performance Year-to-date4.4% Volatility daily2.83% Volatility weekly6.32%
Volatility monthly12.95% Volatility yearly44.86% Relative Volume806.1% Average Volume579.13 K
New High New Low-1.08%

News

2019-10-19 08:42:13 | Accuray NASDAQ:ARAY Has A Somewhat Strained Balance Sheet

2019-10-10 16:05:00 | Accuray To Report Fiscal 2020 First Quarter Financial Results on October 29, 2019

2019-10-08 10:04:02 | AngioDynamics Boosts VIT Product Portfolio With New Buyout

2019-10-03 10:58:02 | Luminex Gets FDA Nod for ARIES MRSA Assay, Boosts Platform

2019-09-29 08:53:37 | Is It Time To Consider Buying Accuray Incorporated NASDAQ:ARAY?

2019-09-19 07:30:00 | Accuray Educates Radiation Oncology Practices on the Potential Impact of the Proposed Alternative Payment Model RO-APM

2019-09-18 10:23:02 | The Rise of Robots in Surgery Puts Spotlight on These 3 Stocks

2019-09-18 09:25:01 | Accuray's ARAY CyberKnife Delivers Improved Patient Outcome

2019-09-17 18:30:00 | Data Published in The Lancet Oncology Suggest CyberKnife® Prostate Patients Experienced Lower Levels of Acute Genitourinary Toxicity Grade 2 or Higher Than Patients Treated on a Conventional Linear Accelerator

2019-09-16 05:45:00 | China Announces Tariff Exclusion for Medical Linear Accelerators

2019-09-14 09:30:01 | Why Is Accuray ARAY Down 1% Since Last Earnings Report?

2019-09-12 16:05:00 | Accuray Appoints Healthcare Veteran James M. Hindman to Board of Directors

2019-09-10 07:30:00 | Geisinger Medical Center is First in Pennsylvania to Treat Cancer Patients with Accuray Radixact® System

2019-09-09 09:22:01 | Here's Why Investors Should Retain Accuray ARAY Stock Now

2019-09-06 06:34:18 | Have Insiders Been Selling Accuray Incorporated NASDAQ:ARAY Shares?

2019-09-04 07:30:00 | Accuray to Host ASTRO Investor Meeting on September 16, 2019

2019-08-23 18:48:05 | Accuray Inc ARAY Files 10-K for the Fiscal Year Ended on June 30, 2019

2019-08-21 07:30:00 | Froedtert & the Medical College of Wisconsin Cancer Network is First in the World to Treat Cancer Patient Using the Accuray Radixact® System with Synchrony® Motion Tracking and Correction Technology

2019-08-16 12:33:00 | Here's Why Accuray Stock Is Nosediving Today

2019-08-16 09:47:01 | Accuray ARAY Reports Loss in Q4, Revenues Beat Estimates

2019-08-16 06:00:00 | No Hooray for Accuray in Q4

2019-08-16 01:41:28 | Edited Transcript of ARAY earnings conference call or presentation 15-Aug-19 8:30pm GMT

2019-08-15 21:23:24 | Accuray Inc ARAY Q4 2019 Earnings Call Transcript

2019-08-15 17:25:09 | Accuray ARAY Reports Q4 Loss, Tops Revenue Estimates

2019-08-15 16:05:00 | Accuray Reports Fourth Quarter and Fiscal 2019 Financial Results

2019-08-15 07:33:31 | Earnings Outlook For Accuray

2019-08-14 13:10:01 | Does Accuray Incorporated's NASDAQ:ARAY CEO Salary Compare Well With Others?

2019-08-08 10:30:02 | Accuray ARAY Earnings Expected to Grow: What to Know Ahead of Next Week's Release

2019-07-24 07:30:00 | New Data Demonstrating Benefits of Accuray Software Solutions Presented at the Annual Meeting of the American Association of Physicists in Medicine

2019-07-23 07:30:00 | Accuray Provides Update on China Joint Venture Operational Progress

2019-07-19 07:30:00 | Accuray To Report Fiscal 2019 Fourth Quarter and Full Year Financial Results on August 15, 2019

2019-07-18 07:30:00 | Swiss Medical Network Advances Cancer Care in Switzerland with Multi-System Agreement for Accuray Radiation Therapy Systems and RaySearch Oncology Software Systems

2019-07-12 10:15:34 | How Does Investing In Accuray Incorporated NASDAQ:ARAY Impact The Volatility Of Your Portfolio?

2019-06-23 20:55:10 | Is Accuray Incorporated ARAY A Good Stock To Buy?

2019-06-12 15:10:10 | How Many Accuray Incorporated NASDAQ:ARAY Shares Do Institutions Own?

2019-06-05 10:05:02 | AngioDynamics Divests NAMIC Portfolio to Medline Industries

2019-05-07 15:31:33 | Volatility 101: Should Accuray NASDAQ:ARAY Shares Have Dropped 47%?

2019-05-01 16:10:00 | Hong Kong Sanatorium & Hospital Signs Agreement at ESTRO to Acquire the Synchrony® Motion Tracking and Correction Technology for the Accuray Radixact® System

2019-05-01 10:00:02 | Varian's VAR Halcyon to Treat Patients at Japan's Hospital

2019-04-24 18:08:44 | Edited Transcript of ARAY earnings conference call or presentation 23-Apr-19 8:30pm GMT

2019-04-24 10:40:02 | Accuray ARAY Q3 Earnings Top Estimates, Gross Orders Rise

2019-04-24 07:30:00 | Accuray Launches Synchrony® Motion Tracking and Correction Technology for the Radixact® System

2019-04-23 21:49:45 | Accuray Inc ARAY Q3 2019 Earnings Call Transcript

2019-04-23 18:15:10 | Accuray ARAY Reports Q3 Loss, Misses Revenue Estimates

2019-04-23 17:09:11 | Accuray: Fiscal 3Q Earnings Snapshot

2019-04-23 16:05:00 | Accuray Reports Fiscal 2019 Third Quarter Results

2019-04-23 14:30:00 | Accuray Incorporated to Host Earnings Call

2019-04-16 10:31:02 | Accuray ARAY May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

2019-04-11 08:33:12 | Here's Why Investors Should Retain Accuray ARAY Stock Now

2019-04-09 09:41:01 | Varian Medical's VAR ProBeam Installed in China's HIMC